The efficacy and safety of mycophenolate mofetil in Thai neuromyelitis optica spectrum disorder patients
Background: Neuromyelitis optica spectrum disorder (NMOSD) often leaves patients with a residual disability after each attack. Several studies have demonstrated that mycophenolate mofetil (MMF) effectively prevents relapse in NMOSD. So far, there has been no data on the effectiveness, dosage, and sa...
Saved in:
Main Author: | Pathomrattanapiban C. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/85767 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
The efficacy and safety of mycophenolate mofetil in Thai neuromyelitis optica spectrum disorder patients
by: Charinya Pathomrattanapiban, et al.
Published: (2022) -
Racial differences in neuromyelitis optica spectrum disorder
by: Su Hyun Kim, et al.
Published: (2019) -
Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review
by: Naphattalung Y.
Published: (2023) -
Efficacy and safety of monoclonal antibody therapy in patients with neuromyelitis optica spectrum disorder: A systematic review and network meta-analysis
by: Aungsumart S.
Published: (2023) -
Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand
by: Sasitorn Siritho, et al.
Published: (2018)